Cargando…
Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment—A Systematic Literature Review
The economic burden of rheumatoid arthritis (RA) on society is high. Disease-modifying antirheumatic drugs (DMARDs) are the cornerstone of therapy. Biological DMARDs are reported to prevent disability and improve quality of life, thus reducing indirect RA costs. We systematically reviewed studies on...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721219/ https://www.ncbi.nlm.nih.gov/pubmed/31426543 http://dx.doi.org/10.3390/ijerph16162966 |